Notification of Changes to Labelling and Package Leaflets in accordance with article 61(3)
Office use only:
Application received on:
PLEASE USE THE GUIDELINES FOR FURTHER INFORMATION.
1.1 (b) Active substance/s:
1.1 (c) Pharmaceutical Form:
1.1 (e) Marketing Authorisation Number/s:
LI019-05 Appendix 2 Version 01
2 Authorisation Holder / Contact Person/s
2.1 Marketing Authorisation Holder
2.2 Person / Company Authorised for Communication / Signing of documents on behalf of the Authorisation Holder
LI019-05 Appendix 2 Version 01
This notification is submitted under Article 61(3) of Council Directive 2001/83/EC. I hereby confirm that the conditions associated with the change have been met and that no other changes have been introduced.
3.2 Date when proposed change will be implemented
3.3 Name of the Applicant (Block Letters):
Signature/s:
Kindly fill in the Declaration form at the following link http://www.medicinesauthority.gov.mt/onlineapplications
A Declaration form should be submitted for each signatory.
LI019-05 Appendix 2 Version 01
Changes notified fall into the following categories:
(Give a brief explanation for the proposed changes to labelling and /or package leaflet.
Provide one full mock-up of the currently approved labelling and package leaflet, one full mock up of the proposed labelling and package leaflet (hard and electronic copies) clearly indicating the proposed changes)
LI019-05 Appendix 2 Version 01